Alterity Therapeutics LTD revenue

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Alterity Therapeutics LTD: revenue history, annual

Fiscal year	2016Jun 2016	2017Jun 2017	2018Jun 2018
Revenue	104	100	156
Growth on the year before	—	−3.9%	+56.1%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Alterity Therapeutics LTD	$155,962	56.1%	—
Celldex Therapeutics, Inc.	$158,000	-97.3%	-63.5%
Clene Inc.	$197,000	-31.1%	-36.9%
Ibio, Inc.	$100,000	-75.0%	-62.4%
Lisata Therapeutics, Inc.	$100,000	-90.7%	—
AIM Immunotech Inc.	$95,000	-21.5%	-17.3%

Compare with peers

• Celldex Therapeutics, Inc. revenue
• Clene Inc. revenue
• Ibio, Inc. revenue
• Lisata Therapeutics, Inc. revenue
• AIM Immunotech Inc. revenue

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Alterity Therapeutics LTD's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Alterity Therapeutics LTD.